Pancreatic Cancer Research

ResearcherChina Pharmaceutical UniversityActive in the last 2 years

Peng Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4530-2400; OpenAlex author ID A5080700790, A5100432789. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 2 papers · 2024: none · 2025: none · 2026: 1 paper

Papers 4

  1. Integrin β6-Targeted CAR-T Cells exhibit potent antitumor activity in β6-Positive pancreatic ductal adenocarcinoma and lung adenocarcinoma. Last author DOI 10.1158/1535-7163.mct-25-1246↗
  2. Establishment of organoid models for pancreatic ductal adenocarcinoma and screening of individualized therapy strategy. Co-author DOI 10.1002/ame2.12352↗
  3. Role of N6‑methyladenosine in the pathogenesis, diagnosis and treatment of pancreatic cancer (Review). Last author DOI 10.3892/ijo.2022.5452↗
  4. RN1, a novel galectin-3 inhibitor, inhibits pancreatic cancer cell growth in vitro and in vivo via blocking galectin-3 associated signaling pathways. Co-author DOI 10.1038/onc.2016.306↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tong Ye · 1 shared paper, 2023 · strength 0.24
  2. Shuxin Sun · 1 shared paper, 2026 · strength 0.23
  3. Lingchao Shi · 1 shared paper, 2026 · strength 0.23
  4. Changhong Shi · 1 shared paper, 2023 · strength 0.19
  5. Miaomiao Gong · 1 shared paper, 2023 · strength 0.19
  6. Jiaze An · 1 shared paper, 2023 · strength 0.19
  7. L Zhang · 1 shared paper, 2017 · strength 0.07
  8. Kan Ding · 1 shared paper, 2017 · strength 0.07
  9. Chenghao Shao · 1 shared paper, 2017 · strength 0.07
  10. Yi Qin · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.